The present invention relates to carboxamide derivative compounds of
formula I in which R1-R6 and R12 are hereinafter defined and together
comprise carboximide derivatives for the therapeutic treatment of
diabetes, hyperglycemia, lipid and carbohydrate metabolism disorders,
arteriosclerotic manifestations and disorders and other blood sugar
related disorders through a metabolic blood sugar-lowering action.